Evidence map›Paper›PMID 25201465›Full record

ArticleBone2014

Fibulin-1 is required for bone formation and Bmp-2-mediated induction of Osterix.

Marion A Cooley, Keerthi Harikrishnan, James A Oppel, Sloan F Miler, Jeremy L Barth, Courtney J Haycraft, Sakamuri V Reddy, W Scott Argraves

Open access · greenAbstract read
In one paragraph

Article in Bone, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Anatomical and immunohistochemical analyses of the fusion of the premaxillary-maxillary suture in human fetuses.Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Noise-Induced Dysregulation ofThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marion A CooleyDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Oral Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA. Electronic address: cooleyma@musc.edu.
Keerthi HarikrishnanDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
James A OppelDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Sloan F MilerDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Jeremy L BarthDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Courtney J HaycraftDepartment of Oral Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Sakamuri V ReddyCharles P. Darby Children's Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA.
W Scott ArgravesDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Medical University of South Carolina · US

Funding

South Carolina IDeA Networks of Biomedical Research (SC INBRE V)P20GM103499 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI EDIE C GOLDSMITH · 2012 to 2026
$61.0M
THE ROLE OF THE RNA BINDING PROTEIN LA IN ORAL TUMOR BIOLOGYP20RR017696 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SOMMER, GUNHILD · 2002 to 2011
$20.7M
SC COBRE for Developmentally Based Cardiovascular DiseasesP30GM103342 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KERN, MICHAEL J · 2012 to 2016
$5.5M
Pilot and Feasibility Project ProgramP30GM103331 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIRKWOOD, KEITH L · 2012 to 2016
$5.2M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROUCH, ROSALIE K · 2002 to 2002
$2.0M
Fibulin-1 Regulation of the DiGeorge Syndrome Pathogenesis PathwayR01HL095067 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ARGRAVES, WILLIAM SCOTT · 2009 to 2012
$1.5M
Role of Fibulin-1 in APP ProcessingR21AG043718 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI ARGRAVES, KELLEY M, KINDY, MARK S. · 2013 to 2014
$411k
NCRR NIH HHS 5P20RR017696NCRR NIH HHS C06 RR015455NCRR NIH HHS P20 RR017696NHLBI NIH HHS R01 HL095067NHLBI NIH HHS R01HL095067NIA NIH HHS 5R21AG043718NIA NIH HHS R21 AG043718NIGMS NIH HHS P20 GM103499NIGMS NIH HHS P30GM10331NIGMS NIH HHS P30 GM103331NIGMS NIH HHS P30 GM103342
6 · The paper itself

Abstract

The extracellular matrix protein Fibulin-1 (Fbln1) has been shown to be involved in numerous processes including cardiovascular and lung development. Here we have examined the role of Fbln1 in bone formation. Alizarin red staining of skulls from Fbln1-deficient mice showed reduced mineralization of both membranous and endochondral bones. MicroCT (μCT) analysis of the calvarial bones (i.e., frontal, parietal and interparietal bones collectively) indicated that bone volume in Fbln1 nulls at neonatal stage P0 were reduced by 22% (p=0.015). Similarly, Fbln1 null frontal bones showed a 16% (p=0.035) decrease in bone volume, with a reduction in the interfrontal bone, and a discontinuity in the leading edge of the frontal bone. To determine whether Fbln1 played a role in osteoblast differentiation during bone formation, qPCR was used to measure the effects of Fbln1 deficiency on the expression of Osterix (Osx), a transcription factor essential for osteoblast differentiation. This analysis demonstrated that Osx mRNA was significantly reduced in Fbln1-deficient calvarial bones at developmental stages E16.5 (p=0.049) and E17.5 (p=0.022). Furthermore, the ability of Bmp-2 to induce Osx expression was significantly diminished in Fbln1-deficient mouse embryo fibroblasts. Together, these findings indicate that Fbln1 is a new positive modulator of the formation of membranous bone and endochondral bone in the skull, acting as a positive regulator of Bmp signaling.

Indexed as

AnimalsBone Morphogenetic Protein 2Calcium-Binding ProteinsCell DifferentiationImmunohistochemistryIn Situ Nick-End LabelingMiceMice, KnockoutOsteoblastsOsteogenesisReal-Time Polymerase Chain ReactionSp7 Transcription FactorTranscription FactorsTranscriptomeBmp2 protein, mouseBone Morphogenetic Protein 2Calcium-Binding ProteinsfibulinSp7 protein, mouseSp7 Transcription FactorTranscription FactorsBmp-2Extracellular matrix proteinFibulin-1Osteoblast differentiationOsterix

Identifiers

PMID25201465
PMCPMC4385289
OpenAlexW2085658708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.